Europe’s first dedicated framework for artificial intelligence in GMP manufacturing is close to finalisation and...
In this exclusive interview from CPHI 2023, Mohamed Noor, Digitalization Manager at the National Institute...
CEP holders are invited to submit feedback on draft monographs for fifteen substances.
The move strengthens Evonik’s capabilities to manufacture increasing complexi APIs at its site in Lafayette, Indiana.
Acquisition set to bolster Vertex’s rare disease portfolio with addition of two potentially best-in-class endocrine assets.
European Commission’s approval brings a chemotherapy-free therapeutic option to patients and develops AbbVie’s oncology and antibody portfolio.